GB1052589A - - Google Patents

Info

Publication number
GB1052589A
GB1052589A GB1052589DA GB1052589A GB 1052589 A GB1052589 A GB 1052589A GB 1052589D A GB1052589D A GB 1052589DA GB 1052589 A GB1052589 A GB 1052589A
Authority
GB
United Kingdom
Prior art keywords
vessel
solutions
natural
layers
gel
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
Publication of GB1052589A publication Critical patent/GB1052589A/en
Active legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/507Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials for artificial blood vessels
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/3604Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix characterised by the human or animal origin of the biological material, e.g. hair, fascia, fish scales, silk, shellac, pericardium, pleura, renal tissue, amniotic membrane, parenchymal tissue, fetal tissue, muscle tissue, fat tissue, enamel
    • A61L27/3625Vascular tissue, e.g. heart valves
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/3683Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix subjected to a specific treatment prior to implantation, e.g. decellularising, demineralising, grinding, cellular disruption/non-collagenous protein removal, anti-calcification, crosslinking, supercritical fluid extraction, enzyme treatment
    • A61L27/3691Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix subjected to a specific treatment prior to implantation, e.g. decellularising, demineralising, grinding, cellular disruption/non-collagenous protein removal, anti-calcification, crosslinking, supercritical fluid extraction, enzyme treatment characterised by physical conditions of the treatment, e.g. applying a compressive force to the composition, pressure cycles, ultrasonic/sonication or microwave treatment, lyophilisation

Abstract

1,052,589. Artificial veins, arteries &c. H. THIELE. July 26, 1965 [July 25, 1964], No. 31863/65. Heading A5R. The invention relates to a process in which a natural vein or like vessel is dissolved and an artificial vein or like vessel is subsequently reconstituted from solution. The term "like vessel" is defined to include arteries, for example aortas, and other blood vessels, tracheae and like tubular body parts. The invention comprises, in one aspect, producing a series of solutions, in each of which is dissolved a histologically defined layer of a natural body vessel and from which may be prepared artificial body vessels, by the steps of causing a natural vessel to swell, mechanically separating the swollen vessel into layers according to the histological structure of the vessel, and separately dissolving each layer in a solvent without affecting the protein components of the layer. Advantageously, the vessel is separted into extema, media and intima layers from which layers three solutions may be obtained. The solvent for the layers may be a weak organic acid, for example pyruvic, lactic, tartaric or citric acid, or an alkaline solution, for example a solution of an alkali metal hydroxide such as sodium hydroxide, or of urea or a derivative of urea, or a solution of an alkali metal thiocyanate, for example lithium thiocyanate. The layers preferably are dissolved at a temperature not greater than 27‹C. to minimise physiological damage. Prior to being caused to swell, the natural vessel may be treated with a defattening agent, for example methanol, ethanol or acetone, either alone or mixed with dimethoxy methane; a suitable agent comprises a mixture of 4 volumes methanol and 1 volume dimethoxy methane. After being defatted, the natural vessel may be treated with an agent to dissolve out the mucopolysaccharides and uronic acids that are present; this agent, which may be an aqueous acid or alkaline solution, for example aqueous sodium hydroxide, may also be capable of swelling the natural vessel so that such dissolution and swelling occur simultaneously. By successively causing a series of solutions, prepared as above, to gel and precipitate around a mould of the desired shape, there may be obtained an artificial body vessel constituted by superposed layers of the gel's formed from each solution and having a histological structure corresponding to that of the original natural vessel. If mucopolysaccharides and uronic acids were removed from the natural vessel after defattening, these substances are added to the series of solutions prior to the gelling and precipitation stress. The superposed layers of the gel may subsequently be immersed in blood serum to absorb serum components. The solutions may be caused to gel and precipitate by allowing gel-forming ions, for example hydrogen ions or multivalent metal cations (calcium, copper, cadmium, aluminium and lantharum cations are specified), to diffuse into the solutions, or by suitably adjusting the pH of the solutions, or by electrophoresis using the mould as a membrane in an electrodialyzer. After gelling and precipitation have been effected the metal cations may be exchanged with hydrogen ions by treatment with, for example, dilute acetic acid; excess hydrogen ions may be removed by dialysis.
GB1052589D Active GB1052589A (en)

Publications (1)

Publication Number Publication Date
GB1052589A true GB1052589A (en)

Family

ID=1757091

Family Applications (1)

Application Number Title Priority Date Filing Date
GB1052589D Active GB1052589A (en)

Country Status (1)

Country Link
GB (1) GB1052589A (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007003324A3 (en) * 2005-06-30 2007-08-16 Transtissue Technologies Gmbh Cell-free graft consisting of a matrix and a serum
US8734828B2 (en) 2006-10-06 2014-05-27 Biotissue Ag Matrix-gel graft without cells

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007003324A3 (en) * 2005-06-30 2007-08-16 Transtissue Technologies Gmbh Cell-free graft consisting of a matrix and a serum
AU2006265361B2 (en) * 2005-06-30 2009-10-22 Biotissue Ag Cell-free graft consisting of a matrix and a serum
JP4871356B2 (en) * 2005-06-30 2012-02-08 ビオティッシュー アーゲー Cell-free graft
DE102005030614B4 (en) * 2005-06-30 2014-05-08 Biotissue Ag Cell-free graft, its use, process for its preparation, matrix thus produced with gel and process for the preparation of this matrix with gel
US9125871B2 (en) 2005-06-30 2015-09-08 Biotissue Ag Cell-free graft
US8734828B2 (en) 2006-10-06 2014-05-27 Biotissue Ag Matrix-gel graft without cells

Similar Documents

Publication Publication Date Title
DE3645226C2 (en)
JP4230135B2 (en) Method for producing glycosaminoglycan-collagen complex cross-linked by multifunctional cross-linking agent
Hedbys The role of polysaccharides in corneal swelling
JP3337472B2 (en) Wound healing agent
Schurer et al. The use of polyethyleneimine for demonstration of anionic sites in basement membranes and collagen fibrils.
US3673612A (en) Non-thrombogenic materials and methods for their preparation
US4420339A (en) Collagen fibers for use in medical treatments
WO2022089295A1 (en) Method for preparing bionic collagen aqueous solution and use method thereof
JPS6237020B2 (en)
CN102380128A (en) Hydroxyapatite, sodium hyaluronate and konjac glucomannan composite material and preparation method thereof
CN110204746A (en) A kind of preparation method of cross-linking sodium hyaluronate gel
CN110339398A (en) One kind Amvisc containing amino acid and preparation method thereof
CN100512889C (en) Process of making cornea histoengineering support in bionic structure
WO2022089287A1 (en) Preparation method and use method for biomimetic collagen solution for skin surface
GB1052589A (en)
Dische et al. The neutral heteropolysaccharides in connective tissue
CN110229357B (en) Preparation method of cross-linked hyaluronic acid gel
Duke-Elder The physico-chemical properties of the vitreous body
US3553299A (en) Process of producing shaped optical bodies useful as aids to vision
CN110845640B (en) Heparinoid sulfonated citric acid modified chitosan and preparation method thereof
US2831851A (en) Polysulfuric acid esters of n-formyl chitosan
CN113384749A (en) Multifunctional hydrogel for promoting long-acting opening of blood circulation and preparation method thereof
CN112390900A (en) Method for extracting chitosan from snow crab shells
CN116159192B (en) Injectable hemostatic anti-adhesion hydrogel and preparation method thereof
CN116772523B (en) Freeze-drying method of collagen sponge